Author:

• Beatriz de Toledo Minguzzi - Minguzzi, BT - <beatrizminguzzi@gmail.com>
ORCID: https://orcid.org/0009-0008-5262-4401

Co-author(s):

• Adriane Lopes Medeiros Simone - Simone, ALM - <adrianelopesmedeiros@gmail.com>
ORCID: https://orcid.org/0000-0002-2045-1146
• Bruna Bento dos Santos - Santos, BB - <brunabentods@gmail.com>
ORCID: https://orcid.org/0000-0002-6291-0857
• Daniela Oliveira de Melo - Melo, DO - <melo.daniela@unifesp.br>
ORCID: https://orcid.org/0000-0001-8613-7953

Abstract:

The integrality of care is one of the principles of the National Pharmaceutical Assistance Policy and underpins two tools that guide the use of medicines: the Clinical Protocols and Therapeutic Guidelines (PCDT) and the Lists of Essential Medicines. Municipalities are encouraged to use them for healthcare management, but the development of municipal lists (Remume) presents fragilities. Objective: To describe potential impacts on the implementation of PCDT from the perspective of the unavailability of medicines from the Basic Component of Pharmaceutical Assistance (CBAF) in Remume. Methods: The CBAF medicines included in PCDT until June 2023 were extracted. Forty-eight municipalities were selected for Remume searching and verification of the medicines of interest. Each PCDT was analyzed according to the lack of the least found medicines. Results: The Remume contained, on average, 60% (44-75%) of the listed medicines, and the average coverage of each PCDT ranged from 2% to 100%. Of 62, 11 PCDT were impacted by the low availability of medicines. Conclusion: A lack of coverage of CBAF medicines in Remume was identified, which may challenge the implementation of PCDT, highlighting the relevance of greater integration of federal entities in the construction of public policies.

Keywords:

National Policy of Pharmaceutical Assistance, Integrality in Health, Practice Guideline

Content:

Access Issue in Scielo

Other languages: